Insider Trading Activity For Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP)
Yuval Cohen , CEO of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) reportedly Bought 1,160 shares of the company’s stock at an average price of 6.89 for a total transaction amount of $7,992.40 SEC Form
Insider Trading History For Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP)
Analyst Ratings History For Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP)
- On 11/30/2016 Aegis Reiterated Rating Buy with a price target of $12.00
- On 4/3/2017 JMP Securities Reiterated Rating Outperform with a price target of $20.00 to $27.00
- On 1/19/2018 Raymond James Financial Initiated Coverage of rating Outperform to Outperform with a price target of $24.00
- On 3/12/2018 Cantor Fitzgerald Set Price Target of rating Buy with a price target of $32.00
- On 3/13/2018 Noble Financial Reiterated Rating Buy
Recent Trading Activity for Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP)
Shares of Corbus Pharmaceuticals Holdings Inc closed the previous trading session at with 6.900000095367432 shares trading hands.